These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 33883825)
1. Preliminary study of urinary excretion of liver-type fatty acid-binding protein in a cat model of chronic kidney disease. Watanabe A; Ohata K; Oikawa T; Sugaya T; Miyazaki M; Satoh H; Katayama M Can J Vet Res; 2021 Apr; 85(2):156-160. PubMed ID: 33883825 [TBL] [Abstract][Full Text] [Related]
2. Renal expression and urinary excretion of liver-type fatty acid-binding protein in cats with renal disease. Katayama M; Ohata K; Miyazaki T; Katayama R; Wakamatsu N; Ohno M; Yamashita T; Oikawa T; Sugaya T; Miyazaki M J Vet Intern Med; 2020 Mar; 34(2):761-769. PubMed ID: 32087614 [TBL] [Abstract][Full Text] [Related]
3. Urinary liver-type fatty acid-binding protein in clinically healthy elderly cats: Evaluation of its potential to detect IRIS stage 1 chronic kidney disease and borderline proteinuria. Kongtasai T; Paepe D; Mortier F; Marynissen S; Meyer E; Duchateau L; Daminet S Vet Med Sci; 2023 Jan; 9(1):3-12. PubMed ID: 36418182 [TBL] [Abstract][Full Text] [Related]
4. Liver-type fatty acid-binding protein and neutrophil gelatinase-associated lipocalin in cats with chronic kidney disease and hyperthyroidism. Kongtasai T; Meyer E; Paepe D; Marynissen S; Smets P; Mortier F; Demeyere K; Vandermeulen E; Stock E; Buresova E; Defauw P; Duchateau L; Daminet S J Vet Intern Med; 2021 May; 35(3):1376-1388. PubMed ID: 33723886 [TBL] [Abstract][Full Text] [Related]
5. Temporal changes in urinary excretion of liver-type fatty acid binding protein (L-FABP) in acute kidney injury model of domestic cats: a preliminary study. Katayama M; Miyazaki T; Ohata K; Oikawa T; Kamiie J; Sugaya T; Miyazaki M J Vet Med Sci; 2019 Dec; 81(12):1868-1872. PubMed ID: 31645505 [TBL] [Abstract][Full Text] [Related]
6. Renal shear wave elastography and urinary procollagen type III amino-terminal propeptide (uPIIINP) in feline chronic kidney disease. Thanaboonnipat C; Sutayatram S; Buranakarl C; Choisunirachon N BMC Vet Res; 2019 Feb; 15(1):54. PubMed ID: 30744640 [TBL] [Abstract][Full Text] [Related]
7. Urinary liver-type fatty acid binding protein as a useful biomarker in chronic kidney disease. Kamijo A; Sugaya T; Hikawa A; Yamanouchi M; Hirata Y; Ishimitsu T; Numabe A; Takagi M; Hayakawa H; Tabei F; Sugimoto T; Mise N; Omata M; Kimura K Mol Cell Biochem; 2006 Mar; 284(1-2):175-82. PubMed ID: 16532260 [TBL] [Abstract][Full Text] [Related]
8. Clinical evaluation of urinary excretion of liver-type fatty acid-binding protein as a marker for the monitoring of chronic kidney disease: a multicenter trial. Kamijo A; Sugaya T; Hikawa A; Yamanouchi M; Hirata Y; Ishimitsu T; Numabe A; Takagi M; Hayakawa H; Tabei F; Sugimoto T; Mise N; Kimura K J Lab Clin Med; 2005 Mar; 145(3):125-33. PubMed ID: 15871303 [TBL] [Abstract][Full Text] [Related]
9. Urinary F Whitehouse W; Quimby J; Wan S; Monaghan K; Robbins R; Trepanier LA J Vet Intern Med; 2017 Mar; 31(2):449-456. PubMed ID: 28160524 [TBL] [Abstract][Full Text] [Related]
11. Renal biomarkers in cats: A review of the current status in chronic kidney disease. Kongtasai T; Paepe D; Meyer E; Mortier F; Marynissen S; Stammeleer L; Defauw P; Daminet S J Vet Intern Med; 2022 Mar; 36(2):379-396. PubMed ID: 35218249 [TBL] [Abstract][Full Text] [Related]
12. Response of urinary liver-type fatty acid-binding protein to contrast media administration has a potential to predict one-year renal outcome in patients with ischemic heart disease. Fujita D; Takahashi M; Doi K; Abe M; Tazaki J; Kiyosue A; Myojo M; Ando J; Fujita H; Noiri E; Sugaya T; Hirata Y; Komuro I Heart Vessels; 2015 May; 30(3):296-303. PubMed ID: 24554034 [TBL] [Abstract][Full Text] [Related]
13. Urinary D-amino acid profiles in cats with chronic kidney disease. Kimura R; Ueda R; Tsujimura H; Ban T; Tanaka A J Vet Med Sci; 2024 Aug; 86(8):855-859. PubMed ID: 38853004 [TBL] [Abstract][Full Text] [Related]
14. Kidney function and glucose metabolism in overweight and obese cats. Pérez-López L; Boronat M; Melián C; Brito-Casillas Y; Wägner AM Vet Q; 2020 Dec; 40(1):132-139. PubMed ID: 32315583 [No Abstract] [Full Text] [Related]
15. Urine hemojuvelin in cats with naturally occurring kidney disease. Jing H; Hsu WL; Wu VC; Tsai HJ; Tsai SF; Tsai PJ; Lai TS; Lee YJ J Vet Intern Med; 2020 May; 34(3):1222-1230. PubMed ID: 32324955 [TBL] [Abstract][Full Text] [Related]
16. Urinary heat shock protein-72: A novel marker of acute kidney injury and chronic kidney disease in cats. Chen H; Avital Y; Bruchim Y; Aroch I; Segev G Vet J; 2019 Jan; 243():77-81. PubMed ID: 30606443 [TBL] [Abstract][Full Text] [Related]
17. Urinary excretion of liver-type fatty acid-binding protein as a marker of progressive kidney function deterioration in patients with chronic glomerulonephritis. Mou S; Wang Q; Li J; Shi B; Ni Z Clin Chim Acta; 2012 Jan; 413(1-2):187-91. PubMed ID: 21958699 [TBL] [Abstract][Full Text] [Related]
18. Urinary Liver-Type Fatty Acid Binding Protein, a Biomarker for Disease Progression, Dialysis and Overall Mortality in Chronic Kidney Disease. Mitsides N; Mitra V; Saha A; Harris S; Kalra PA; Mitra S J Pers Med; 2023 Oct; 13(10):. PubMed ID: 37888092 [TBL] [Abstract][Full Text] [Related]
19. Analysis of a urinary biomarker panel for obstructive nephropathy and clinical outcomes. Xie Y; Xue W; Shao X; Che X; Xu W; Ni Z; Mou S PLoS One; 2014; 9(11):e112865. PubMed ID: 25402279 [TBL] [Abstract][Full Text] [Related]
20. Urinary cytokine levels in apparently healthy cats and cats with chronic kidney disease. Habenicht LM; Webb TL; Clauss LA; Dow SW; Quimby JM J Feline Med Surg; 2013 Feb; 15(2):99-104. PubMed ID: 22989558 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]